Chemokines in rheumatic diseases

Z Szekanecz, G Szucs, S Szántó… - Current drug targets, 2006 - ingentaconnect.com
Chemotactic cytokines, termed chemokines, mediate the ingress of leukocytes into the
inflamed synovium. In this review, authors discuss the role of the most relevant chemokines …

Chemokines in rheumatic diseases

Z Szekanecz, G Szücs, S Szántó… - Current drug …, 2006 - pubmed.ncbi.nlm.nih.gov
Chemotactic cytokines, termed chemokines, mediate the ingress of leukocytes into the
inflamed synovium. In this review, authors discuss the role of the most relevant chemokines …

[引用][C] Chemokines in Rheumatic Diseases

Z Szekanecz, G Szucs, S Szanto, A Koch - Current Drug Targets, 2006 - cir.nii.ac.jp
Chemokines in Rheumatic Diseases | CiNii Research CiNii 国立情報学研究所 学術情報
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす …

Chemokines in rheumatic diseases.

Z Szekanecz, G Szücs, S Szántó, AE Koch - Current Drug Targets, 2006 - europepmc.org
Chemotactic cytokines, termed chemokines, mediate the ingress of leukocytes into the
inflamed synovium. In this review, authors discuss the role of the most relevant chemokines …

[引用][C] Chemokines in rheumatic disease

Z SZEKANECZ - Curr Drug Targets, 2006 - cir.nii.ac.jp